Kura Oncology Grants Stock Options To New Hires Under Inducement Plan
(RTTNews) - Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company focused on precision cancer therapies, announced that its Board's Compensation Committee granted nonstatutory stock options for 79,200 shares to five new employees on June 2, 2025.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
